Nebramycin

Suppliers

Names

[ CAS No. ]:
11048-13-8

[ Name ]:
Nebramycin

[Synonym ]:
(2S,3R,4S,5S,6R)-4-Amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol
Tobramaxin
VZ8RRZ51VK
(1S,2S,3R,4S,6R)-4,6-Diamino-3-[(2,6-diamino-2,3,6-trideoxy-α-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-α-D-glucopyranoside
Tobramycin Base
2990
Nebcin
Obramycin
Tobralex
EINECS 256-499-2
Burlamycin
α-D-Glucopyranoside, (1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-α-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-
MFCD00077885
(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-a-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-a-D-glucopyranoside
(2S,3R,4S,5S,6R)-4-Amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)tetrahydro-2H-pyran
Tobracin
distobram
MFCD00133864
Tobramycin
4-[2,6-Diamino-2,3,6-trideoxy-a-D-glycopyranosyl]-6-[3-amino-3-deoxy-a-D-glycopyranosyl]-2-deoxystreptamine
a-D-glucopyranoside, (1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-a-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-
(2S,3R,4S,5S,6R)-4-amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminométhyl)-5-hydroxytétrahydro-2H-pyran-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxyméthyl)tétrahydro-2H-pyran-3,5-diol
O-3-Amino-3-deoxy-a-D-glucopyranosyl-(1®6)-O-[2,6-diamino-2,3,6-trideoxy-a-D-ribo-hexopyranosyl(1®4)]-2-deoxy-D-streptamine
Tobrex

Chemical & Physical Properties

[ Density]:
1.5±0.1 g/cm3

[ Boiling Point ]:
775.4±60.0 °C at 760 mmHg

[ Molecular Formula ]:
C18H37N5O9

[ Molecular Weight ]:
467.514

[ Flash Point ]:
422.8±32.9 °C

[ Exact Mass ]:
467.259125

[ LogP ]:
-3.41

[ Vapour Pressure ]:
0.0±6.0 mmHg at 25°C

[ Index of Refraction ]:
1.651

Related Compounds

  • Nebramycin V'
  • NEBRAMYCIN II
  • Nebramycin vii
  • NEBRAMYCIN FACTOR 12
  • NEBRAMYCIN FACTOR 11
  • NEBRAMYCIN FACTOR 13
  • Tert-butyl (4-bromothiazol-2-yl)(4-methoxybenzyl)carbamate
  • (S)-2-Bromo-1-(3-cyclopropyl-7-fluoro-2,3-dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)ethan-1-one
  • (R)-2-Bromo-1-(3-cyclopropyl-7-fluoro-2,3-dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)ethan-1-one
  • 2-bromo-1-[7-fluoro-3-(trifluoromethyl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]ethanone
  • Methyl 7-Bromo-4-oxoisochroman-3-carboxylate
  • Methyl 2-(((tert-butoxycarbonyl)amino)methyl)thiophene-3-carboxylate
  • 5-(Difluoromethyl)-2-piperidin-1-ylaniline
  • Benzyl {4-[4-(tert-butyl-dimethyl-silanoyloxymethyl)-pyrazol-1-yl]-3-fluoro-phenyl}-carbamate
  • 5-(2-Phenylphenyl)-1,3-oxazolidin-2-one
  • N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-((R)-3-(allyloxy)-2-(((allyloxy)carbonyl)amino)-3-oxopropyl)-L-homocysteine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.